The maker of Viagra, Lipitor and Advil has been slashing thousands of jobs since acquiring rival Wyeth in 2009.
Now, as several of its key products run out of patent protection, it is also downsizing its research and development spending.
The company plans to still cut another 5,530 employees -- or 5% of its global workforce. While many of those jobs cuts will come from the closure of a factory in Sandwich, England, they will also affect many U.S. employees who work in R&D roles.
These young job seekers graduated into the worst labor market since the Great Depression.
|Plugging in this date will permanently crash your iPhone|
|Carrier workers' rage over move to Mexico caught on video|
|Joe Scarborough-Donald Trump friendship increasing source of discomfort at NBC|
|You can reserve Tesla's low-cost Model 3 starting March 31 February 11|
|Under Sanders, income and jobs would soar, economist says|